Cargando…

Effect of pimobendan on physical fitness, lactate and echocardiographic parameters in dogs with preclinical mitral valve disease without cardiomegaly

Pimobendan has gained enormous importance in the treatment of mitral valve disease in dogs. The current consensus statement of the American College of Veterinary Internal Medicine (ACVIM) recommends a treatment for dogs with symptomatic disease and dogs with asymptomatic disease with radiographic an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iwanuk, Nayeli, Wall, Leona, Nolte, Ingo, Raue, Jonathan, Rumstedt, Katja, Pilgram, Anna, Sehn, Maximiliane, Rohn, Karl, Bach, Jan-Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776412/ https://www.ncbi.nlm.nih.gov/pubmed/31581204 http://dx.doi.org/10.1371/journal.pone.0223164

Ejemplares similares

Effect of Pimobendan on NT-proBNP and c troponin I before and after a submaximal exercise test in dogs with preclinical mitral valve disease without cardiomegaly – a randomised, double-blinded trial
por: Iwanuk, Nayeli, et al.
Publicado: (2019)

The effect of treatment with pimobendan in dogs with preclinical mitral valve disease – a placebo-controlled double-blinded crossover study
por: Klein, Stephanie, et al.
Publicado: (2021)

Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study—A Randomized Clinical Trial
por: Boswood, A., et al.
Publicado: (2016)

Evaluation of new and old biomarkers in dogs with degenerative mitral valve disease
por: Klein, Stephanie, et al.
Publicado: (2022)

Effect of pimobendan on left atrial function in dogs with preclinical myxomatous mitral valve disease
por: Sarcinella, Fabio, et al.
Publicado: (2019)

Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Preclinical Myxomatous Mitral Valve Disease Receiving Pimobendan or Placebo: The EPIC Study
por: Boswood, A., et al.
Publicado: (2017)

Clinical use of submaximal treadmill exercise testing and assessments of cardiac biomarkers NT-proBNP and cTnI in dogs with presymptomatic mitral regurgitation
por: Wall, Leona, et al.
Publicado: (2018)

A newborn with cardiomegaly
por: Upadhyay, Shailendra, et al.
Publicado: (2010)

Pharmacokinetics of pimobendan after oral administration to dogs with myxomatous mitral valve disease
por: McManamey, Anna K., et al.
Publicado: (2023)

Echocardiographic indices and severity of mitral regurgitation in dogs with preclinical degenerative mitral valve disease
por: Larouche‐Lebel, Éva, et al.
Publicado: (2019)

Massive pleural effusion and cardiomegaly
por: Son, Min-Ji, et al.
Publicado: (2023)

Pharmacodynamics and Pharmacokinetics of Injectable Pimobendan and Its Metabolite, O-Desmethyl-Pimobendan, in Healthy Dogs
por: Pichayapaiboon, Poonavit, et al.
Publicado: (2021)

Pharmacokinetics of Pimobendan and Its Metabolite O-Desmethyl-Pimobendan Following Rectal Administration to Healthy Dogs
por: Her, Jiwoong, et al.
Publicado: (2020)

Methods of Radiographic Measurements of Heart and Left Atrial Size in Dogs with and without Myxomatous Mitral Valve Disease: Intra- and Interobserver Agreement and Practicability of Different Methods
por: Levicar, Charanthorn, et al.
Publicado: (2022)

Pimobendan B from powder diffraction data
por: Zvirgzdins, Alvis, et al.
Publicado: (2013)

Repeated-Dose Pharmacodynamics of Pimobendan in Healthy Cats
por: Sugimoto, Keisuke, et al.
Publicado: (2022)

Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial
por: Wess, Gerhard, et al.
Publicado: (2020)

Splenomegaly, Cardiomegaly, and Osteoporosis in a Child with Gaucher Disease
por: Sheth, J. J., et al.
Publicado: (2011)

Efficacy of Pimobendan in the Prevention of Congestive Heart Failure or Sudden Death in Doberman Pinschers with Preclinical Dilated Cardiomyopathy (The PROTECT Study)
por: Summerfield, NJ, et al.
Publicado: (2012)

Pimobendan prevents cardiac dysfunction, mitigates cardiac mitochondrial dysfunction, and preserves myocyte ultrastructure in a rat model of mitral regurgitation
por: Boonpala, Pakit, et al.
Publicado: (2023)

Effects of pimobendan on left atrial transport function in cats
por: Kochie, Samantha L., et al.
Publicado: (2020)

Echocardiographic evaluation of mitral geometry in functional mitral regurgitation
por: Sadeghpour, Anita, et al.
Publicado: (2008)

Cardiomegaly Masquerading as a Pediatric Thymoma: A Case Report
por: Figlewicz, Matthew R, et al.
Publicado: (2020)

The clinical associations with cardiomegaly in patients undergoing evaluation for pulmonary hypertension
por: Daines, Benjamin, et al.
Publicado: (2021)

Letter regarding “Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial”
por: Oyama, Mark A., et al.
Publicado: (2021)

Impact of a combination of pimobendan, furosemide, and enalapril on heart rate variability in naturally occurring, symptomatic, myxomatous mitral valve degeneration dogs
por: Pirintr, Prapawadee, et al.
Publicado: (2023)

Echocardiographic assessment of ischemic mitral regurgitation
por: Dudzinski, David M, et al.
Publicado: (2014)

Utility of radiographic measurements to predict echocardiographic left heart enlargement in dogs with preclinical myxomatous mitral valve disease
por: Poad, Megan H., et al.
Publicado: (2020)

Long‐term Outcome of Irish Wolfhound Dogs with Preclinical Cardiomyopathy, Atrial Fibrillation, or Both Treated with Pimobendan, Benazepril Hydrochloride, or Methyldigoxin Monotherapy
por: Vollmar, A.C., et al.
Publicado: (2016)

Letter to the editor regarding “Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial”
por: Atkins, Clarke, et al.
Publicado: (2021)

Massive Cardiomegaly due to Dilated Cardiomyopathy Causing Bronchial Obstruction in an Infant
por: Lee, Ji Eun, et al.
Publicado: (2014)

Cardiomegaly found in hospitalized patients with novel coronavirus disease (COVID-19)
por: Shankayi, Zeinab, et al.
Publicado: (2022)

A prospective, randomized, double‐blind, placebo‐controlled pilot study of sacubitril/valsartan (Entresto) in dogs with cardiomegaly secondary to myxomatous mitral valve disease
por: Newhard, Daniel K., et al.
Publicado: (2018)

Response to letter to editor regarding “Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial”
por: Wess, Gerhard, et al.
Publicado: (2021)

Response to letter to the editor regarding “Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial”
por: Wess, Gerhard, et al.
Publicado: (2021)

Comparison of the effects of long-term pimobendan and benazepril administration in normal cats
por: MIYAGAWA, Yuichi, et al.
Publicado: (2016)

Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity
por: Yuan, Si-Yu, et al.
Publicado: (2022)

Atypical manifestations of cardiomegaly and nephrotic syndrome in Kawasaki disease: Two case reports
por: Wang, Liyuan, et al.
Publicado: (2019)

Aortic Arch Calcification and Cardiomegaly Are Associated with Overall and Cardiovascular Mortality in Hemodialysis Patients
por: Ou, Shih-Hsiang, et al.
Publicado: (2021)

Correlation Between Anemia (Hemoglobin Level) and Cardiomegaly Based On Chest Radiograph and Echocardiography
por: Amelia, Putri, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fkl58vn7mbhh7mkihp5e8ojalp